CLOVER HEALTH INVESTMENTS, CORP. current report, 17 May 2021

Clover Health Investments, Corp. Form 8-K Summary

Business Context and Reporting Period

Filed May 17, 2021, under Item 4.02(a). The filing addresses the accounting treatment of public and private placement warrants issued in connection with Social Capital Hedosophia Holdings Corp. III’s business combination with Legacy Clover, completed January 7, 2021.

Financial Reporting Issue and Key Metrics

  • The Company determined that its public and private placement warrants should be classified as liabilities, rather than equity, and measured at fair value each reporting period, with changes in fair value reported in earnings.
  • As of December 31, 2020, there were 27,599,938 public warrants and 10,933,333 private placement warrants outstanding.
  • The filing does not provide the resulting fair-value adjustment, revised earnings, balance-sheet impact, or other updated financial metrics.
  • The historical audited financial statements of Legacy Clover are not affected by this warrant-classification issue.

Material Change Versus Previously Reported Information

On May 16, 2021, the Audit Committee concluded that the warrants had been incorrectly classified as equity in Social Capital Hedosophia Holdings Corp. III’s previously issued financial statements for the year ended December 31, 2020. Those financial statements, included in the Company’s 2020 Form 10-K, should no longer be relied upon.

The Company also stated that previously released financial information and disclosures concerning Social Capital Hedosophia Holdings Corp. III for periods in 2020, including related reports, press releases, earnings releases, investor presentations, and specified registration-statement disclosures, should no longer be relied upon.

Management Commentary, Risks, and Contingencies

  • The accounting conclusion followed an April 12, 2021 SEC staff statement regarding accounting and reporting considerations for SPAC warrants.
  • The Audit Committee and management discussed the matter with Ernst & Young LLP, the Company’s independent registered public accounting firm.
  • Reclassification to liability accounting may create earnings volatility because warrant fair values will be remeasured each reporting period.
  • The filing provides no earnings guidance or updated outlook.

Investor Verification Checklist

  • Verify the amended or restated financial statements and the precise effect of the warrant reclassification on liabilities, equity, net income, and accumulated results.
  • Confirm the fair value and valuation methodology for the public and private placement warrants at each reporting date.
  • Review subsequent filings for any revised disclosures, audit conclusions, or impact on regulatory filings and registration statements.
  • Assess potential period-to-period earnings volatility from recurring warrant fair-value changes.